The Phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from Mutation of RPE65 and Differentiation from Leber Congenital Amaurosis

Overview of attention for article published in Investigative Ophthalmology & Visual Science, January 2011

Altmetric Badge

Mentioned by

policy: 1 policy source

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

Voretigene Neparvovec: An Emerging Gene Therapy for the Treatment of Inherited Blindness

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 13 Mar 2018

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Gene Therapy: International Regulatory and Health Technology Assessment (HTA) Activities and Reimbursement Status

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 28 Nov 2017

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.